Hepatocyte-specific FBXW5 overexpression aggravated diet-induced metabolic disorders in the liver and activated ASK1-associated MAPK signaling in the liver, according to an in vivo study; however, hepatocyte-specific FBXW5 deficiency significantly inhibited the progression of these abnormalities (44). This evidence concerns the gene FBXW5 and Other metabolic disease.